With more than twenty years of experience in the health industry Mr. Cabello is currently the Scientific Director of the venture capital company Cross Road Biotech (CRB) and head of the Molecular Genetics Laboratory of the Ramón and Cajal Hospital in Madrid. He specialized in molecular Genetics in the Center of Human Genetics of the University of Leuven and has published numerous articles in this field. Mr. Cabello holds a degree in Biological Sciences from the Universidad Autónoma of Madrid where he also completed graduate courses of Human Genetics.
Dr. Castellon holds a Bachelor of Medicine and Surgery (UCM) and Specialist in Internal Medicine. Bachelor of Economic and Business Sciences (UAM). Master in Public Health and Master in Health Policy and Management from Harvard University. He began as a doctor in the Internal Medicine Department of the Hospital Clínico San Carlos de Madrid and belonged to the Social Security Medical Inspectorate, being responsible for planning of INSALUD in La Coruña. He was later Director General of the Galicia Health Service (1991-1995). In CAM he was the Vice Director of Health and Social Services and later Undersecretary of the MSC (1996-2000). Dr. Castellon set up the Spanish National Cancer Research Center (CNIO), the Spanish National Center for Cardiovascular Research (CNIC) and the Spanish Regulatory Agency of which he was Executive Chairman until 2000. He has collaborated as an advisor with various research foundations concerned with health sciences and has been a consultant for Banco Mundial. Dr. Castellon currently serves as the president of the venture capital company Cross Road Biotech, of which he is one of the founders.
Mr. Santos has extensive experience in the international business world, acquired over 25 years in Spain, the UK and USA in businesses such as Johnson’s Wax and Lilly. In his final period at Johnson he was Vice Chair of Marketing and Operations for the professional business in North America, where he was responsible for the development of strategy and solutions for the health and food service markets. Before becoming part of Johnson, he worked for Lilly in a variety of positions and divisions of the pharmaceutical group. He has been an Advisor for the Center for Hospitality Research of the Hotel Management School at Cornell University. Mr. Santos is an Agronomist (Universidad Politécnica de Madrid) and has been involved in numerous specialized postgraduate courses. He is currently a partner the venture capital company Cross Road Biotech.
Mr. Armero joined the venture capital firm Clave Mayor in 2012, as Managing Director of the Valladolid Office, where he has served as a non-executive director in more than 5 companies related to the life science sector. Before joining Clave Mayor, Mr. Armero worked for KPMG for more than 8 years, where he held the position of manager at KPMG Valladolid office and as Chief Financial Officer of ADE Parques for more than 8 years. Mr. Armero holds a B.A. in Economics (University of Valladolid) and a Master in Tax Consulting from IE Business School (Madrid, Spain) and Master in Audit and Finance from University of Alcalá (Madrid, Spain).
with over 25 years of experience in the venture capital industry, Mr. Fernandez is a seasoned investment professional. In 1987 he joined the venture capital firm ADE Capital Sodical (Sodical), taking on the role of the fund's CEO in 1998. Prior to joining Sodical, Mr. Fernandez filled various management and consultancy positions in companies such as Roland Berger S.A. Mr. Fernandez holds a university degree in Industrial Engineering from the Superior Technical Scholl for Industrial Engineering of the Polytechnic University of Madrid. Mr. Fernandez specialized in Business Administration, completed various postgraduate studies and authored a number of publications.
All rights reserved. 2011 TCD Pharma                                         Legal Statement                                                          Designed by Freeman y la luz